LTBR
Tumor necrosis factor receptor superfamily member 3
Also known as: D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3, TNR3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P36941
- Gene
- LTBR
- Ensembl
- ENSG00000111321
- Chromosome
- 12
- Canonical length
- 435 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
This gene encodes a member of the tumor necrosis factor receptor superfamily. The major ligands of this receptor include lymphotoxin alpha/beta and tumor necrosis factor ligand superfamily member 14. The encoded protein plays a role in signalling during the development of lymphoid and other organs, lipid metabolism, immune response, and programmed cell death. Activity of this receptor has also been linked to carcinogenesis. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2012]
Canonical amino-acid sequenceUniProt
435 residues, UniProt reviewed canonical sequence.
>P36941|LTBR
1 MLLPWATSAP GLAWGPLVLG LFGLLAASQP QAVPPYASEN QTCRDQEKEY YEPQHRICCS
61 RCPPGTYVSA KCSRIRDTVC ATCAENSYNE HWNYLTICQL CRPCDPVMGL EEIAPCTSKR
121 KTQCRCQPGM FCAAWALECT HCELLSDCPP GTEAELKDEV GKGNNHCVPC KAGHFQNTSS
181 PSARCQPHTR CENQGLVEAA PGTAQSDTTC KNPLEPLPPE MSGTMLMLAV LLPLAFFLLL
241 ATVFSCIWKS HPSLCRKLGS LLKRRPQGEG PNPVAGSWEP PKAHPYFPDL VQPLLPISGD
301 VSPVSTGLPA APVLEAGVPQ QQSPLDLTRE PQLEPGEQSQ VAHGTNGIHV TGGSMTITGN
361 IYIYNGPVLG GPPGPGDLPA TPEPPYPIPE EGDPGPPGLS TPHQEDGKAW HLAETEHCGA
421 TPSNRGPRNQ FITHDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LTBR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 137 nTPM
Expression across tissuesHPA
Tissue
- liver: 137 nTPM
- esophagus: 84 nTPM
- pancreas: 81 nTPM
- skin: 77 nTPM
- colon: 73 nTPM
- stomach: 69 nTPM
Single-cell type
- esophageal apical cells: 193 nCPM
- alveolar cells type 1: 151 nCPM
- enterocytes: 113 nCPM
- esophageal suprabasal cells: 104 nCPM
- esophageal basal cells: 91 nCPM
- prostatic hillock cells: 82 nCPM
Immune cell
- classical monocyte: 71 nTPM
- intermediate monocyte: 66 nTPM
- non-classical monocyte: 50 nTPM
- myeloid DC: 50 nTPM
- neutrophil: 45 nTPM
- total PBMC: 27 nTPM
Brain region
- medulla oblongata: 21 nTPM
- pons: 19 nTPM
- thalamus: 18 nTPM
- choroid plexus: 17 nTPM
- spinal cord: 16 nTPM
- midbrain: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.31
- gnomAD missense Z
- 2.03
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cellular response to mechanical stimulus
- immune response
- myeloid dendritic cell differentiation
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of extrinsic apoptotic signaling pathway
- positive regulation of JNK cascade
- signal transduction
- hematopoietic or lymphoid organ development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TNFR/NGFR cysteine-rich region
- TNFR/NGFR cysteine-rich region
- Tumour necrosis factor receptor 3
- Tumour necrosis factor receptor 3, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LTBR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LTBR as an antibody target. Whether an autoantibody or antibody against LTBR could matter depends on whether native LTBR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LTBR is annotated at the cell surface, where native LTBR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LTBR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...